Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1237-1241

  Capodanno, Davide ^a,b   Capranzano, Piera ^a   Giacchi, Giuseppe ^a   Calvi, Valeria ^a   Tamburino, Corrado ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b ETNA Foundation   (Italy)

Author keywords

Apixaban; Dabigatran; Rivaroxaban

Indexed keywords

APIXABAN; DABIGATRAN ETEXILATE; RIVAROXABAN; WARFARIN;

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; DRUG SAFETY; EMBOLISM; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS; MORTALITY; NON VALVULAR ATRIAL FIBRILLATION; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

APIXABAN; DABIGATRAN; RIVAROXABAN;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; WARFARIN;

EID: 84881477376     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.148     Document Type: Article

References (11)

1. R.G. Hart, L.A. Pearce, and M.I. Aguilar Metaanalysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
2. J. Mant, F.D. Hobbs, and K. Fletcher Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503
3. D.E. Singer, G.W. Albers, and J.E. Dalen Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 546S 592S
4. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
5. E. Birman-Deych, M.J. Radford, and D.S. Nilasena Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation Stroke 37 2006 1070 1074
6. E.M. Hylek, C. Evans-Molina, and C. Shea Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 2007 2689 2696
7. D. Capodanno, and D.J. Angiolillo Antithrombotic therapy in the elderly J Am Coll Cardiol 56 2010 1683 1692
8. S.J. Connelly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus Warfarin in Patients with Atrial Fibrillation N Engl J Med 361 2009 1139 1151
9. M. Patel, K.W. Mahffey, and J. Garg Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation N Engl J Med 365 10 2011 883 891
10. C.B. Granger, J.H. Alexander, and J.J.V. McMurray Apixaban versusWarfarin in Patients with Atrial Fibrillation N Engl J Med 365 11 2011 981 992
11. J. Ansell New oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation Circulation 125 2012 165 170